mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.07 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.08 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.08 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.08 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.09 |
mRNA |
methylstat |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.09 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.09 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |